Prior to Nuvilex, Ryan worked as the CEO of RFR Consulting where he focused on helping businesses in the biotech industry through providing information, grant writing, business management, scientific guidance, FDA regulatory advice, advising investors, and investment acquisition opportunities.
Nuvilex board of directors chairman Patricia Gruden said Robert understands the science behind the company’s products while also possessing the leadership and business expertise to lead Nuvilex toward long-term, sustainable growth.
"His experience with developing biotech products and his proven track record, knowledge, and experience with the rigorous FDA approval process make him an ideal candidate for leading Nuvilex to develop revolutionary products, partnering with other companies, and moving those products to market," Gruden said.